INTERNATIONAL PATENT: KEYMED BIOSCIENCES (CHENGDU) CO., LTD., 康诺亚生物医药科技（成都）有限公司, CHENGDU KANGNUOXING BIOPHARMA, INC., 成都康诺行生物医药科技有限公司 FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATE TARGETING CEACAM5 AND USE THEREOF"

Posted On: 2025-11-30

GENEVA, Nov. 30 -- KEYMED BIOSCIENCES (CHENGDU) CO., LTD. (Building D2, No. 18 Bio-Town Middle Road, Chengdu Tianfu International Bio-Town, Shuangliu DistrictChengdu, Sichuan 610219), 康诺亚生物医药科技（成都）有限公司 (中国四川省成都市双流区天府国际生物城生物城中路18号D2栋), CHENGDU KANGNUOXING BIOPHARMA, INC. (Building D2, No. 18 Bio-Town Middle Road, Chengdu Tianfu International Bio-Town, Shuangliu DistrictChengdu, Sichuan 610219), 成都康诺行生物...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: KEYMED BIOSCIENCES (CHENGDU) CO., LTD., 康诺亚生物医药科技（成都）有限公司, CHENGDU KANGNUOXING BIOPHARMA, INC., 成都康诺行生物医药科技有限公司 FILES APPLICATION FOR "ANTIBODY-DRUG CONJUGATE TARGETING CEACAM5 AND USE THEREOF"